You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 7, July 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Use of Injectable Cultured Human Fibroblasts for Percutaneous Tissue Implantation

An Experimental Study

Daniel Remmler, MD; J. Regan Thomas, MD; Gwen Mazoujian, MD; Alice Pentland, MD; Kenneth Schechtman, PhD; Sharon Favors; Eugene Bauer, MD

Arch Otolaryngol Head Neck Surg. 1989;115(7):837-844.


Abstract

• Large quantities of cultured human facial dermal fibroblasts were propagated from randomly selected patients to determine their relative suitability as percutaneously injectable living implants. Volumetric and histologic comparisons were made between the following implants that were injected subcutaneously into athymic nude mice: (1) cultured human fibroblasts (HFb); (2) cultured human fibroblasts dispersed in Zyderm II collagen (HFb + Zyd); (3) Zyderm II collagen (Zyd); and (4) Zyplast collagen (Zyp). Both the HFb and HFb + Zyd implants were accepted as primary takes but regressed volumetrically at significantly greater rates than either the Zyd or Zyp implants. Correlative immunohistochemical staining revealed that, by 10 days, 90% of the cells within the HFb implants and 80% within the HFb + Zyd implants were of human origin; however, by 9 weeks, approximately 25% of the cells were of human origin in both types of implants. These results indicated that cultured human fibroblasts can be successfully injected as living grafts; however, the subsequent gradual attrition in the numbers of implanted cells, as noted in this model system, limits the long-term retention of the implants.

(Arch Otolaryngol Head Neck Surg. 1989;115:837-844)



Author Affiliations

From the Department of Otolaryngology–Head and Neck Surgery, Division of Facial Plastic and Reconstructive Surgery (Drs Remmler and Thomas), the Department of Pathology (Dr Mazoujian), the Department of Medicine, Division of Dermatology (Drs Pentland and Bauer and Ms Favors), and the Department of Biostatistics (Dr Schechtman), Washington University School of Medicine, St Louis, Mo.


Footnotes

Accepted for publication January 27, 1989.

Read before the American Academy of Facial Plastic and Reconstructive Surgery at the Combined Otolaryngological Spring Meeting, Palm Beach, Fla, April 29, 1988.

Reprint requests to Department of Otolaryngology–Head and Neck Surgery, Division of Facial Plastic and Reconstructive Surgery, Washington University School of Medicine, Box 8115, 4911 Barnes Hospital Plaza, St Louis, MO 63110 (Dr Thomas).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.